Healthcare

Hologen and Sysmex establish AI blood-intelligence joint venture

Hologen and Sysmex formed Saibogen to use generative AI on routine hematology data and produce additional clinical intelligence without new samples or instruments.

Hologen and Sysmex announced Saibogen, a joint venture focused on applying generative AI to routine blood-test data. Saibogen will use Hologen’s Large Medicine Models with proprietary data generated by Sysmex hematology analyzers. The companies aim to extract additional clinical and research insights from detailed blood-count data without requiring new instruments, reagents or samples. The initial products are intended for research use only. The venture combines Sysmex’s hematology technology and data with Hologen’s AI models. The development illustrates how generative AI is being applied to existing diagnostic data rather than requiring new testing infrastructure.

Original source: GlobeNewswire

Related RAQI solutions

In-depth analysis on RAQI Insight

Work with RAQI